ABC News
Johnson & Johnson will spend more than $14 billion to move deeper into treating central nervous system disorders by purchasing Intra-Cellular Therapies…
Read More
J&J buys Intra-Cellular in $14.6B deal, delving into central nervous system disorders
Johnson & Johnson will spend more than $14 billion to move deeper into treating central nervous system disorders by purchasing Intra-Cellular Therapies…